Synairgen Aims To Disprove Doubts About Interferon Therapy In COVID-19

Nebulized Formulation ‘Is Key’

 
• By Andrew McConaghie
Hospital blur
Synairgen will shortly launch a Phase III trial of its nebulized interferon beta treatment in hospitalized patients.

More from Business

More from Scrip